Clinical Design Technologies Ltd. is a UK-based startup that has developed the Urine Testing System (UTS), which is positioned as the world’s first closed, digital urine testing system. Their solution aims to revolutionize urine testing at point-of-care, addressing the critical need for fast, accurate, and easy-to-use urinalysis. The UTS™️ boasts features such as automatic sample readings, eliminating manual timing and color interpretation, and ensuring accurate and reliable results. The system is designed with a patient-centric approach, focusing on simplicity, ease of use, and hygienic operation. It holds the approval of a Class A in vitro diagnostic device and is manufactured in Cornwall, UK, with the support of the European Regional Development Fund and the South West AHSN Digital Accelerator Programme. The company prides itself on consistently demonstrating 100% compliance with industry and clinical standard tolerances. As of now, there is no publicly disclosed information regarding the company's last investment or investors. Clinical Design Technologies operates in the Health Care and Medical Devices industries, showing promise in its efforts to disrupt the traditional methods of urine testing.
There is no investment information
No recent news or press coverage available for Clinical Design Technologies Ltd..